Bone and Mineral Metabolism Disorders

Top Story

KDIGO seeks comments on updating guidelines for treating hepatitis C in chronic kidney disease patients

October 15, 2015

European Commission approves ferric citrate to treat hyperphosphatemia in CKD patients not on dialysis

September 27, 2015
The European Commission has approved Fexeric (ferric citrate coordination complex) for the control of elevated serum phosphorus levels, or hyperphosphatemia…

DOPPS Practice Monitor shows increase in PTH levels, changes in medications due to ESRD bundle

September 7, 2015
The Dialysis Outcomes and Practice Patterns Study (DOPPS) practice monitor (DPM) is showing several apparent practice changes related specifically to mineral…

Amgen submits application with FDA for new secondary hyperparathyroidism drug

August 25, 2015
Amgen has submitted a new drug application with the U.S. Food and Drug Administration for etelcalcetide (formerly AMG 416) to treat secondary hyperparathyroidism in…
More Headlines »

Toward the Individualization of Treatment for Patients with Hyponatremia

This activity is supported by an educational grant from Otsuka America Pharmaceutical, Inc.

Hyponatremia is the most common electrolyte imbalance observed in patients, occurring in up to 30% of hospitalizations…
More »
PerspectiveOpen Access

Health Literacy and Medication Management in Chronic Kidney Disease

HLRP: Health Literacy Research and Practice, Summer 2017, Volume 1 Issue 3
Chronic kidney disease (CKD) is the progressive decline of kidney function, which may eventually lead to kidney failure…
More »

HIV Curbside Consults – Volume II: HIV Treatment in Patients with Comorbidities

This activity is supported by an educational grant from ViiV Healthcare.

In this case-based video, Eric S. Daar, MD and Paul E. Sax, MD discuss the management of an older man with long-term…
More »
Meeting News Coverage

VIDEO: Giullian discusses goals of incident dialysis alternative payment model

March 16, 2018
More »